Bodal Chemicals Ltd
Bodal Chemicals Limited is one of India’s leading integrated Dyestuff companies and is the largest domestic manufacturer of Dye Intermediates. It offers a wide range of Dyestuffs, Dye Intermediates, Basic Chemicals, and its variants to diverse customers across India and the world. [1]
- Market Cap ₹ 893 Cr.
- Current Price ₹ 70.9
- High / Low ₹ 81.9 / 41.2
- Stock P/E 18.7
- Book Value ₹ 91.9
- Dividend Yield 0.00 %
- ROCE 6.68 %
- ROE 4.23 %
- Face Value ₹ 2.00
Pros
- Stock is trading at 0.77 times its book value
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of 10.4% over past five years.
- Tax rate seems low
- Company has a low return on equity of 2.65% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Dyes And Pigments
Part of BSE Commodities
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1,043 | 908 | 1,233 | 1,142 | 1,424 | 1,375 | 1,226 | 2,055 | 1,574 | 1,395 | 1,745 | 2,012 | |
| 859 | 758 | 1,007 | 946 | 1,187 | 1,237 | 1,140 | 1,835 | 1,441 | 1,284 | 1,578 | 1,851 | |
| Operating Profit | 184 | 150 | 226 | 196 | 236 | 138 | 87 | 220 | 133 | 111 | 167 | 161 |
| OPM % | 18% | 16% | 18% | 17% | 17% | 10% | 7% | 11% | 8% | 8% | 10% | 8% |
| 5 | 19 | 15 | 8 | 13 | 10 | 16 | -2 | 12 | 9 | 2 | 42 | |
| Interest | 27 | 12 | 9 | 5 | 9 | 19 | 17 | 29 | 41 | 54 | 82 | 79 |
| Depreciation | 22 | 26 | 29 | 12 | 21 | 28 | 30 | 47 | 53 | 60 | 69 | 70 |
| Profit before tax | 139 | 131 | 204 | 186 | 219 | 101 | 55 | 142 | 51 | 5 | 19 | 54 |
| Tax % | 34% | 34% | 35% | 33% | 35% | 15% | 28% | 31% | 25% | -37% | 4% | 12% |
| 92 | 86 | 133 | 122 | 141 | 86 | 40 | 99 | 38 | 6 | 18 | 48 | |
| EPS in Rs | 8.41 | 7.88 | 12.18 | 10.03 | 11.72 | 7.12 | 3.43 | 8.51 | 3.03 | 0.51 | 1.47 | 3.80 |
| Dividend Payout % | 0% | 8% | 7% | 8% | 7% | 11% | 23% | 9% | 3% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 10% |
| 3 Years: | 9% |
| TTM: | 15% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | -5% |
| 5 Years: | 3% |
| 3 Years: | 9% |
| TTM: | 74% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | -2% |
| 5 Years: | -7% |
| 3 Years: | 3% |
| 1 Year: | -5% |
| Return on Equity | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 4% |
| 3 Years: | 3% |
| Last Year: | 4% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 22 | 22 | 22 | 24 | 24 | 24 | 24 | 24 | 25 | 25 | 25 | 25 |
| Reserves | 135 | 213 | 341 | 673 | 805 | 907 | 957 | 1,028 | 1,053 | 1,057 | 1,080 | 1,132 |
| 234 | 143 | 151 | 181 | 171 | 257 | 454 | 676 | 760 | 904 | 911 | 813 | |
| 144 | 132 | 193 | 194 | 290 | 267 | 314 | 385 | 283 | 294 | 324 | 385 | |
| Total Liabilities | 534 | 510 | 707 | 1,072 | 1,290 | 1,455 | 1,749 | 2,113 | 2,120 | 2,281 | 2,339 | 2,356 |
| 190 | 192 | 222 | 437 | 609 | 656 | 804 | 817 | 967 | 1,314 | 1,301 | 1,239 | |
| CWIP | 3 | 0 | 9 | 19 | 26 | 7 | 14 | 70 | 193 | 68 | 61 | 67 |
| Investments | 2 | 2 | 17 | 17 | 6 | 3 | 6 | 0 | 0 | 13 | 0 | 0 |
| 339 | 316 | 459 | 599 | 650 | 789 | 924 | 1,227 | 960 | 886 | 977 | 1,050 | |
| Total Assets | 534 | 510 | 707 | 1,072 | 1,290 | 1,455 | 1,749 | 2,113 | 2,120 | 2,281 | 2,339 | 2,356 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 198 | 131 | 104 | 7 | 186 | 10 | -13 | -14 | 290 | 204 | 114 | 176 | |
| -35 | -23 | -67 | -256 | -128 | -79 | -168 | -170 | -315 | -278 | -41 | 11 | |
| -162 | -109 | -23 | 236 | -51 | 76 | 178 | 181 | 33 | 81 | -73 | -191 | |
| Net Cash Flow | 0 | -1 | 14 | -13 | 7 | 7 | -3 | -3 | 8 | 7 | -0 | -5 |
| Free Cash Flow | 162 | 107 | 45 | -221 | 38 | -43 | -191 | -170 | -29 | -29 | 69 | 180 |
| CFO/OP | 129% | 111% | 76% | 34% | 106% | 20% | -4% | 11% | 223% | 182% | 65% | 109% |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 69 | 67 | 56 | 91 | 85 | 121 | 139 | 105 | 97 | 100 | 83 | 80 |
| Inventory Days | 43 | 57 | 60 | 59 | 86 | 91 | 141 | 141 | 119 | 139 | 139 | 106 |
| Days Payable | 62 | 67 | 73 | 79 | 91 | 87 | 102 | 81 | 72 | 102 | 97 | 81 |
| Cash Conversion Cycle | 50 | 58 | 43 | 71 | 79 | 124 | 178 | 165 | 144 | 137 | 125 | 105 |
| Working Capital Days | 23 | 18 | 21 | 58 | 50 | 65 | 73 | 55 | 49 | 19 | 20 | 27 |
| ROCE % | 39% | 35% | 46% | 27% | 24% | 11% | 5% | 12% | 5% | 3% | 6% | 7% |
Insights
In beta| Sep 2020 | |
|---|---|
| Total Production Volume (Bodal Chemicals) Metric Tonnes ・Standalone data |
|
Extracted by Screener AI
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
22 May - Bodal Chemicals Limited herewith submit newspaper publication
-
Announcement - Declaration Of Unmodified Opinion Of Audited Financial Results For Year Ended 31St March 2026
21 May - Bodal Chemicals submitted declaration for unmodified audit opinion on FY26 audited results.
-
Announcement under Regulation 30 (LODR)-Investor Presentation
21 May - Bodal Chemicals Limited herewith inform Exchange about Earning Presentation for Q4 - May 2026
-
Board Meeting Outcome for Outcome Of Board Meeting
21 May - Board approved FY26 audited results and sale of inoperative Unit I at market rates.
-
Result - Audited Financial Results For Quarter And Year Ended 31St March 2026
21 May - Board approved FY26 audited standalone and consolidated results, plus sale of inoperative Unit I.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2012
from nse
Concalls
-
May 2026TranscriptAI SummaryPPT
-
Feb 2026TranscriptAI SummaryPPT
-
Nov 2025TranscriptAI SummaryPPT
-
Aug 2025Transcript PPT
-
May 2025Transcript PPT
-
Feb 2025Transcript PPT
-
Nov 2024Transcript PPT
-
Aug 2024Transcript PPT
-
May 2024Transcript PPT
-
Feb 2024Transcript PPT
-
Nov 2023Transcript PPT
-
Aug 2023Transcript PPT
-
Jun 2023Transcript PPT
-
Feb 2023Transcript PPT
-
Nov 2022Transcript PPT
-
Aug 2022Transcript PPT
-
Jun 2022Transcript PPT
-
Feb 2022Transcript PPT
-
Nov 2021Transcript PPT
-
Aug 2021Transcript PPT
-
Jul 2021Transcript PPT
-
Feb 2021Transcript PPT
-
Dec 2020TranscriptAI SummaryPPT
-
Nov 2020Transcript PPT
-
Sep 2020Transcript PPT
-
Aug 2020Transcript PPT
-
Jul 2020Transcript PPT
-
Mar 2020Transcript PPT
-
Feb 2020Transcript PPT
-
Nov 2019Transcript PPT
-
Nov 2019TranscriptAI SummaryPPT
-
Aug 2019Transcript PPT
-
Jun 2019TranscriptPPT
-
May 2019Transcript PPT
-
May 2019TranscriptAI SummaryPPT
-
May 2019TranscriptAI SummaryPPT
-
Mar 2019TranscriptAI SummaryPPT
-
Mar 2019TranscriptAI SummaryPPT
-
Feb 2019Transcript PPT
-
Nov 2018Transcript PPT
-
Oct 2018TranscriptAI SummaryPPT
-
Aug 2018Transcript PPT
-
Aug 2018TranscriptAI SummaryPPT
-
Jun 2018Transcript PPT
-
Jun 2018Transcript PPT
-
May 2018TranscriptAI SummaryPPT
-
Feb 2018Transcript PPT
-
Jan 2018TranscriptAI SummaryPPT
-
Dec 2017Transcript PPT
-
Aug 2017Transcript PPT
-
May 2017Transcript PPT
-
Mar 2017TranscriptAI SummaryPPT
-
Feb 2017TranscriptAI SummaryPPT
-
Nov 2016TranscriptAI SummaryPPT
-
Nov 2016Transcript PPT
-
Aug 2016TranscriptAI SummaryPPT
-
Jun 2016TranscriptAI SummaryPPT
-
Feb 2016TranscriptAI SummaryPPT
Product Portfolio:[1]
a) Basic Chemicals (~12 Products): Sulphuric Acid, Chlorosulphonic Acid, Sulphur Trioxide, Oleum 23% & 65%, Sodium Bisulphate, Acetanilide, Thionyl Chloride, Beta Naphthol, Para Nitro Aniline.
b) Dye Intermediates (~25 Products):
Vinyl Sulphone & Derivatives, H Acid, DASA, F.C. Acid, Gamma Acid, K Acid, Sulpho Tobias Acid, 4.N.A.D.P.S.A, 6-Nitro, MPDSA, Meta Ureido Aniline, 1:2:4 DIAZO
c) Dyestuffs (~175 Products):
Reactive Dyes, Acid Dyes, Direct Dyes, Liquid Dyes
d) Chlor Alkali (~6 Products):
Caustic Soda, Chlorine, Hydrogen, Hydrochloric Acid (HCL), Sodium Hypochlorite (HYPO), Stable Bleaching Powder (SBP)